Clik here to view.
My Genome Online – A Challenge To You
[Editor’s Note: This guest post is contributed by Blaine Bettinger. Blaine is the author of The Genetic Genealogist, a blog that examines the intersection of genetics and ancestry, and a patent...
View ArticleClik here to view.
DTC Genetic Testing and the FDA: is there an end in sight to the regulatory...
Disclaimer: Genomes Unzipped received 12 free kits from Lumigenix for review purposes, and Dan Vorhaus has provided legal advice to the company. We plan to release a full review of the Lumigenix...
View ArticleClik here to view.
Why publish science in peer-reviewed journals?
The recent announcement of a new journal sponsored by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust generated a bit of discussion about the issues in the...
View ArticleThe first steps towards a modern system of scientific publication
About a year ago on this site, I discussed a model for addressing some of the major problems in scientific publishing. The main idea was simple: replace the current system of pre-publication peer...
View Article£100M for whole patient genomes – revolutionising genetic diagnostics or...
On 10th December 2012, UK Prime Minister David Cameron launched a Report on the Strategy for UK Life Sciences One Year On by announcing that the Government has earmarked £100 million to “sequence...
View Article£100M for whole patient genomes – an implementation challenge
The recent announcement that the UK Government has earmarked £100 million to “sequence 100,000 whole genomes of NHS patients at diagnostic quality over the next three to five years” raises a number of...
View ArticleClik here to view.
Do we have an obligation to look?
One of the major bioethical debates in clinical genetics and genomics research is the issue of what to do with incidental or secondary findings (IFs) unrelated to the original clinical or research...
View ArticleClik here to view.
Why predicting the phenotypic effect of mutations is hard
By now, we’re probably all familiar with Niels Bohr’s famous quote that “prediction is very difficult, especially about the future”. Although Bohr’s experience was largely in quantum physics, the same...
View ArticleClik here to view.
ACMG guidelines on IFs – responding to the response…
The ongoing debate about whether, what, when and how to feedback incidental findings (IFs) from whole genome sequencing continues to rage on both sides of the Atlantic following the American College of...
View ArticleClik here to view.
Should the FDA regulate the interpretation of traditional epidemiology?
Last week, the FDA sent a sternly-worded letter to the personal genomics company 23andMe, arguing that the company is marketing an unapproved diagnostic device. Many have weighed in on this, but I’d...
View Article
